| abstract |
The invention relates to pharmacologically active substituted 3-aminosydnone imines of the general formula I <IMAGE> (I) in which R1 denotes (C1-C4)-alkyl, di-(C1-C4)-alkylamino or (C6-C12)-aryl, which can optionally be substituted by (C1-C4)-alkyl; R2 denotes hydrogen or COR3 and R3 denotes (C1-C4)-alkyl, (C1-C4)-alkoxy, (C1-C4)-alkoxy-(C1-C4)-alkyl, acetoxy-(C1-C4)-alkyl, (C6-C12)-aryl, which can be substituted by (C1-C4)-alkyl or (C1-C4)-alkoxy, pyridyl, pyridyl(C1-C4)alkyl or (C3-C8)-cycloalkyl and their pharmacologically acceptable acid addition salts. |